Privia Health Group, Inc. (NASDAQ:PRVA) Position Cut by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 0.7% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 824,523 shares of the company’s stock after selling 5,461 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.69% of Privia Health Group worth $15,015,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group during the second quarter valued at about $26,000. Nisa Investment Advisors LLC raised its stake in shares of Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after purchasing an additional 930 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares in the last quarter. Signaturefd LLC raised its stake in shares of Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after purchasing an additional 626 shares in the last quarter. Finally, KBC Group NV raised its stake in shares of Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on PRVA shares. Barclays lifted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. KeyCorp began coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price target on the stock. Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Truist Financial boosted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. Two research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $24.79.

Insider Buying and Selling at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 14.20% of the company’s stock.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $21.18 on Friday. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $24.30. The stock’s 50-day moving average is $19.54 and its two-hundred day moving average is $18.82. The stock has a market cap of $2.54 billion, a PE ratio of 211.80, a price-to-earnings-growth ratio of 5.63 and a beta of 0.83.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.